Edwards Lifesciences Corporation (EW) vs Koninklijke Philips N.V. (PHG)
- Edwards Lifesciences Corporation EW 101.94 +1.11%
- Koninklijke Philips N.V. PHG 30.29 −0.72%
Edwards Lifesciences Corporation and Koninklijke Philips N.V. are both Medical Devices companies. Edwards Lifesciences Corporation is the larger, with a market value of $58.1B against $29.8B — 1.9× the size. Koninklijke Philips N.V. trades at the lower P/E: 25.8× against 56.7×. Edwards Lifesciences Corporation grew revenue faster over the last twelve months: 13.4% against 7.98%. Edwards Lifesciences Corporation has the higher net margin (15.3% vs 5.34%) and the higher return on invested capital (7.79% vs 6.15%). Across the 22 metrics below, Edwards Lifesciences Corporation leads on 13 and Koninklijke Philips N.V. on 9.
Valuation
Profitability
| Metric | EW | PHG | Medical Devices median |
|---|---|---|---|
| Gross margin | 78.02% | 46.43% | 57.76% |
| Operating margin | 21.59% | 8.68% | (15.07%) |
| Net margin | 15.30% | 5.34% | (14.45%) |
| Free cash flow margin | 21.34% | 10.27% | (3.88%) |
| Return on equity | 9.65% | 8.54% | (10.35%) |
| Return on assets | 7.45% | 3.49% | (17.26%) |
| Return on invested capital | 7.79% | 6.15% | (5.27%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack